Long-term persistence with denosumab: real-world data from the Austrian Osteoporosis Clinic (AOC). A retrospective data analysis

2021 ◽  
Author(s):  
Ewald Boschitsch ◽  
Oliver Naegele ◽  
Anita Klinger ◽  
Harald Brix-Samoylenko
Keyword(s):  
Data Analysis ◽  
Real World ◽  
Retrospective Data ◽  
Real World Data ◽  
World Data ◽  
Retrospective Data Analysis ◽  
Osteoporosis Clinic

Long-term immunity to hepatitis B following vaccination in infancy: Real-world data analysis

Vaccine ◽  
2018 ◽  
Vol 36 (17) ◽  
pp. 2288-2292 ◽  
Author(s):  
Gil Klinger ◽  
Gabriel Chodick ◽  
Itzhak Levy
Keyword(s):  
Data Analysis ◽  
Hepatitis B ◽  
Real World ◽  
Real World Data ◽  
World Data

878-P: Real-World Data from U.S. Patients Using a Long-Term Implantable Continuous Glucose Monitoring (CGM) System: Age Effect on Glycemic Control

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 878-P
Author(s):  
KATHERINE TWEDEN ◽  
SAMANWOY GHOSH-DASTIDAR ◽  
ANDREW D. DEHENNIS ◽  
FRANCINE KAUFMAN
Keyword(s):  
Glycemic Control ◽  
Continuous Glucose Monitoring ◽  
Real World ◽  
Glucose Monitoring ◽  
Age Effect ◽  
Real World Data ◽  
World Data

scholarly journals Pain Pharmacotherapy in a Large Cohort of Patients with Osteoarthritis: A Real-World Data Analysis

2021 ◽  
Author(s):  
Noga Fallach ◽  
Gabriel Chodick ◽  
Matanya Tirosh ◽  
Elon Eisenberg ◽  
Omri Lubovsky
Keyword(s):  
Data Analysis ◽  
Real World ◽  
Large Cohort ◽  
Real World Data ◽  
World Data

scholarly journals Long‐term therapy with botulinum toxin in facial synkinesis: Retrospective data analysis of data from 1998 to 2018

2021 ◽  
Author(s):  
Sara Alipour ◽  
Carina Pick ◽  
Stefanie Jansen ◽  
Svenja Rink ◽  
Jens Peter Klußmann ◽  
...  
Keyword(s):  
Data Analysis ◽  
Botulinum Toxin ◽  
Term Therapy ◽  
Retrospective Data ◽  
Retrospective Data Analysis ◽  
Long Term Therapy ◽  
Facial Synkinesis

Long-term outcome of minimally invasive mitral valve annuloplasty in disproportionate mitral regurgitation

2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
M Albano ◽  
S Nagumo ◽  
M Vanderheyden ◽  
J Bartunek ◽  
C Collet ◽  
...  
Keyword(s):  
Mitral Valve ◽  
Mitral Regurgitation ◽  
Minimally Invasive ◽  
Real World ◽  
Independent Predictor ◽  
Real World Data ◽  
Long Term Outcome ◽  
World Data ◽  
Mitral Valve Annuloplasty

Abstract Background Hypothetical concept of disproportionate secondary mitral regurgitation (SMR) has been recently introduced to facilitate patient's selection for mitral valve intervention. However, real world data validating this concept are unavailable. Purpose To investigate long-term effects of minimally invasive mitral valve annuloplasty (MVA) in patients with disproportionate (dSMR) versus proportionate SMR. Methods The study population consisted of 44 consecutive patients (age 67±9,5 years; 64% males) on guidelines-directed therapy with advanced heart failure (HF), reduced LV ejection fraction (EF) (32±9,7%) and SMR undergoing isolated mini-invasive MVA. Patients with organic mitral regurgitation or concomitant myocardial revascularization were excluded. To assess SMR disproportionality, the PISA-derived effective regurgitant orifice area (EROA) and regurgitant volume (RV) were compared to the estimated EROA and RV by using Gorlin formula and pooled real world data. Results According to EROA, a total of 20 (46%) and 24 (54%) patients, respectively, had dSMR and proportionate SMR (pSMR). According to RV, a total of 17 (39%) had dSMR and 27 (61%) had pSMR. Patients with dSMR showed significantly lower prevalence of male gender and higher prevalence of diabetes mellitus than patients with pSMR (p<0,001). Moreover, we observed smaller LV end-diastolic volume, larger EROA and RV (both p<0,01) and higher LV EF (p=0,02) in the dSMR versus the pSMR group. Other baseline characteristics were similar. During median follow up of 4.39 y (IQR 2,2–9,96y), a total of 25 (56%) patients died from any cause while 21 (47%) individuals were readmitted for worsening HF. Patients with dSMR versus pSMR according to both EROA and RV showed significantly lower rate of HF readmissions (both p<0.05) (Figure 1, 2). In Cox regression analysis combining clinical and imaging parameters, dSMR was the only independent predictor of HF readmissions (HR 0.20, 95% CI 0.07–0.60, p=0.004). In contrast, mortality was similar between dSMR and pSMR (NS) with age as the only independent predictor (HR 1,10; 95% CI 1,03–1,18, p=0,003). Conclusions Minimally invasive MVA is associated with significant reduction of HF readmissions in patients with dSMR versus pSMR while the mortality is similar. This suggests the importance of other parameters, i.e. age and degree of LV remodeling, to guide clinical management in SMR. Funding Acknowledgement Type of funding source: None

scholarly journals Cancer survival statistics for patients and healthcare professionals – a tutorial of real‐world data analysis

2020 ◽  
Vol 289 (1) ◽  
pp. 12-28 ◽  
Author(s):  
S. Eloranta ◽  
K. E. Smedby ◽  
P. W. Dickman ◽  
T. M. Andersson
Keyword(s):  
Data Analysis ◽  
Real World ◽  
Healthcare Professionals ◽  
Cancer Survival ◽  
Real World Data ◽  
World Data
Sign in / Sign up

Export Citation Format

Share Document